Skip to content
Home » Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients

Bridging Policy and Patient Access: Making the EU HTA Regulation Work for Patients

    On Tuesday, 14 October 2025, CPE and Pancreatic Cancer Europe (PCE) hosted a webinar on The Role of EU HTA in National Healthcare: Bridging Policy and Patient Access, bringing together European institutions, national HTA bodies, and patient organisations to discuss the importance of patient involvement in HTA. The webinar focused on how the new EU HTA Regulation can help bridge the gap between policy and real-world access to innovative therapies, ensuring that patients’ perspectives are central to decision-making and timely access across Europe.

    The discussion emphasised that patients are not just recipients of care but experts by experience, whose insights can make health assessments fairer and more relevant. This perspective is now being realised through the EU HTA Regulation, which for the first time gives patients a formal role in shaping access to medicines and medical technologies. Early progress includes multiple Joint Clinical Assessments already underway and increasing patient involvement across Europe, with a clear need for continued investment in training and capacity to ensure meaningful participation. The regulation is part of a broader European policy framework aimed at accelerating innovation and strengthening evidence-based healthcare.

    At the national level, participants shared practical examples of structured patient involvement in HTA, from medical device assessments to networks of patient advocates shaping national decisions. Similar efforts across countries highlighted the importance of clear processes and accessible tools to make engagement practical, consistent, and effective. Patient involvement must be supported by training, guidance, and recognition of its value, with new initiatives designed to empower patients to play an active role in EU-level HTA activities.

    The webinar concluded with a shared vision that the EU HTA Regulation is not just a technical exercise but it is an opportunity to make healthcare more equitable, transparent, and patient-centred.

    For CPE, the path forward is clear. Collaboration will be key to turning the regulation’s promise into practice at every stage of assessment and decision-making.

    CPE PCE HTA Webinar